(Stroke. 1999;30:2713.)
© 1999 American Heart Association, Inc.
Original Contributions |
From the Department of Physiology and Pharmacology (F.D., R.V., F.B., D.W.B.), Department of Pediatrics (J.V.P.), and Stroke Research Center (R.V.), Wake Forest University School of Medicine, Winston-Salem, NC; and Department of Physiology, Albert Szent-Györgyi Medical University, Szeged, Hungary (F.D., F.B.).
Correspondence to David W. Busija, PhD, Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157-1010. E-mail dbusija{at}wfubmc.edu
Background and PurposeN-Methyl-D-aspartate (NMDA) elicits neuronally mediated cerebral arteriolar vasodilation that is reduced by ischemia/reperfusion (I/R). This sequence has been preserved by pretreatment with the ATP-sensitive potassium (KATP) channel opener aprikalim, although the mechanism was unclear. In the heart, mitochondrial KATP channels (mitoKATP) are involved in the ischemic preconditioning-like effect of K+ channel openers. We determined whether the selective mitoKATP channel opener diazoxide preserves the vascular dilation to NMDA after I/R.
MethodsPial arteriolar diameters were determined with the use of closed cranial window/intravital microscopy in anesthetized piglets. Vascular responses to NMDA were assessed before and 1 hour after 10 minutes of global cerebral ischemia induced by raising intracranial pressure. Subgroups received 1 of the following pretreatments before I/R: vehicle; 1 to 10 µmol/L diazoxide; and coapplication of 100 µmol/L 5-hydroxydecanoic acid (5-HD), a KATP antagonist with diazoxide.
ResultsNMDA-induced dose-dependent pial arteriolar dilation was not affected by diazoxide treatment only but was severely attenuated by I/R. In contrast, diazoxide dose-dependently preserved the NMDA vascular response after I/R; at 10 µmol/L, diazoxide arteriolar responses were unaltered by I/R. The effect of diazoxide was antagonized by coapplication of 5-HD with diazoxide. Percent preservation of 100 µmol/L NMDAinduced vasodilation after I/R was 53±19% (mean±SEM, n=8) in vehicle-treated controls versus 55±10%, 85±5%, and 99±15% in animals pretreated with 1, 5, and 10 µmol/L diazoxide (n=8, n=8, and n=12, respectively) and 60±15% in the group treated with 5-HD+diazoxide (n=5).
ConclusionsThe mitoKATP channel opener diazoxide in vivo preserves neuronal function after I/R, shown by pial arteriolar responses to NMDA, in a dose-dependent manner. Thus, activation of mitoKATP channels may play a role in mediating the protective effect of other K+ channel openers.
Department of Anesthesiology, Baylor College of Medicine, Houston, Texas
This article has been cited by other articles:
![]() |
S. Roth, J. C. Dreixler, A. R. Shaikh, K. H. Lee, and V. Bindokas Mitochondrial Potassium ATP Channels and Retinal Ischemic Preconditioning Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 2114 - 2124. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-S. Sun, Z.-P. Feng, T. Miki, S. Seino, and R. J. French Enhanced Neuronal Damage After Ischemic Insults in Mice Lacking Kir6.2-Containing ATP-Sensitive K+ Channels J Neurophysiol, April 1, 2006; 95(4): 2590 - 2601. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Brustovetsky, N. Shalbuyeva, and N. Brustovetsky Lack of manifestations of diazoxide/5-hydroxydecanoate-sensitive KATP channel in rat brain nonsynaptosomal mitochondria J. Physiol., October 1, 2005; 568(1): 47 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Gutterman Mitochondria and Reactive Oxygen Species: An Evolution in Function Circ. Res., August 19, 2005; 97(4): 302 - 304. [Full Text] [PDF] |
||||
![]() |
F. Domoki, B. Kis, K. Nagy, E. Farkas, D. W. Busija, and F. Bari Diazoxide preserves hypercapnia-induced arteriolar vasodilation after global cerebral ischemia in piglets Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H368 - H373. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. V. Cancherini, L. G. Trabuco, N. A. Reboucas, and A. J. Kowaltowski ATP-sensitive K+ channels in renal mitochondria Am J Physiol Renal Physiol, December 1, 2003; 285(6): F1291 - F1296. [Abstract] [Full Text] |
||||
![]() |
Y. Teshima, M. Akao, R. A. Li, T. H. Chong, W. A. Baumgartner, M. V. Johnston, and E. Marban Mitochondrial ATP-Sensitive Potassium Channel Activation Protects Cerebellar Granule Neurons From Apoptosis Induced by Oxidative Stress Stroke, July 1, 2003; 34(7): 1796 - 1802. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Perciaccante, F. Domoki, M. Puskar, and D. W. Busija Effects of hypothermia on neuronal-vascular function after cerebral ischemia in piglets Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2002; 283(6): R1362 - R1367. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shimizu, Z. Lacza, N. Rajapakse, T. Horiguchi, J. Snipes, and D. W. Busija MitoKATP opener, diazoxide, reduces neuronal damage after middle cerebral artery occlusion in the rat Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H1005 - H1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Shake, E. A. Peck, E. Marban, V. L. Gott, M. V. Johnston, J. C. Troncoso, J. M. Redmond, and W. A. Baumgartner Pharmacologically induced preconditioning with diazoxide: a novel approach to brain protection Ann. Thorac. Surg., December 1, 2001; 72(6): 1849 - 1854. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wakamatsu, N. Shiiya, T. Kunihara, S. Watanabe, and K. Yasuda The adenosine triphosphate-sensitive potassium channel opener nicorandil protects the ischemic rabbit spinal cord J. Thorac. Cardiovasc. Surg., October 1, 2001; 122(4): 728 - 733. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, G. Ren, B. O'Rourke, E. Marbán, and J. Seharaseyon Pharmacological Comparison of Native Mitochondrial KATP Channels with Molecularly Defined Surface KATP Channels Mol. Pharmacol., February 1, 2001; 59(2): 225 - 230. [Abstract] [Full Text] |
||||
![]() |
R. Bajgar, S. Seetharaman, A. J. Kowaltowski, K. D. Garlid, and P. Paucek Identification and Properties of a Novel Intracellular (Mitochondrial) ATP-sensitive Potassium Channel in Brain J. Biol. Chem., August 31, 2001; 276(36): 33369 - 33374. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |